Literature DB >> 7010856

Comparison between multi-injection and continuous subcutaneous insulin therapy in insulin-dependent diabetic inpatients.

V Saibene, M Melandri, L Brembilla, D Spotti, G Pozza.   

Abstract

Circadian blood glucose profiles have been evaluated in 8 insulin-dependent diabetic inpatients on their usual home insulin therapy, on a 3-injection regimen (ultralente in the morning plus 3 injections of regular insulin at meals), on continuous subcutaneous insulin infusion by portable micropumps (Mill Hill 1001) and, again, on a 3-injection regimen at the same insulin dose as during continuous subcutaneous insulin infusion. The 3-injection regimen achieved a mean daily blood glucose level comparable to that obtained by continuous subcutaneous insulin infusion, even if significantly more insulin was needed. At comparable insulin doses, continuous subcutaneous insulin infusion provided a significantly lower mean daily blood glucose. Glycemic control at 0600 and 0800 was better during continuous subcutaneous insulin infusion. Low acceptance by the patients of the home use of portable micropumps was evidenced because of the practical and psychological problems involved.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7010856     DOI: 10.1007/bf02056105

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  12 in total

1.  THE M-VALVE, AN INDEX OF BLOOD-SUGAR CONTROL IN DIABETICS.

Authors:  J SCHLICHTKRULL; O MUNCK; M JERSILD
Journal:  Acta Med Scand       Date:  1965-01

2.  Continuous subcutaneous insulin infusion:good blood glucose control for up to 4 days.

Authors:  J C Pickup; H Keen; J A Parsons; K G Alberti
Journal:  Diabetologia       Date:  1979-06       Impact factor: 10.122

3.  Role of continuous component in subcutaneous "open-loop" insulin delivery.

Authors:  J D Nelson; E B Marliss; A M Albisser; B Zinman
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

4.  Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at the injection site.

Authors:  M Berger; P A Halban; L Girardier; J Seydoux; R E Offord; A E Renold
Journal:  Diabetologia       Date:  1979-08       Impact factor: 10.122

5.  Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump.

Authors:  W V Tamborlane; R S Sherwin; M Genel; P Felig
Journal:  N Engl J Med       Date:  1979-03-15       Impact factor: 91.245

6.  Good diabetic control - a study in mass delusion.

Authors:  J I Malone; J M Hellrung; E W Malphus; A L Rosenbloom; A Grgic; F T Weber
Journal:  J Pediatr       Date:  1976-06       Impact factor: 4.406

7.  Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.

Authors:  J C Pickup; H Keen; J A Parsons; K G Alberti
Journal:  Br Med J       Date:  1978-01-28

8.  Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy.

Authors:  R A Rizza; J E Gerich; M W Haymond; R E Westland; L D Hall; A H Clemens; F J Service
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

9.  Restoration of normal lipid and aminoacid metabolism in diabetic patients treated with a portable insulin-infusion pump.

Authors:  W V Tamborlane; R S Sherwin; M Genel; P Felig
Journal:  Lancet       Date:  1979-06-16       Impact factor: 79.321

10.  Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics.

Authors:  J C Pickup; H Keen; J A Parsons; K G Alberti; A S Rowe
Journal:  Lancet       Date:  1979-06-16       Impact factor: 79.321

View more
  3 in total

1.  Continuous subcutaneous insulin infusion: a long-term study.

Authors:  A Lombardo; S Scavino; G Scornavacca; G Oliva; C Sipione; R Cacciola; L Motta
Journal:  Acta Diabetol Lat       Date:  1986 Jan-Mar

2.  Open-loop device Microjet MC 2 improves unstable diabetes, lowers the daily insulin requirement and reduces the excursions of plasma free insulin levels: comparison with a traditional intensive treatment.

Authors:  P Micossi; U Raggi; F Dosio; M Scavini; A Bertin; G Pozza
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

3.  Metabolic control of type I (insulin dependent) diabetes after pancreas transplantation.

Authors:  G Pozza; E Bosi; A Secchi; P M Piatti; J L Touraine; A Gelet; A E Pontiroli; J M Dubernard; J Traeger
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.